These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 25230343)
1. BCL2L12: a promising molecular prognostic biomarker in breast cancer. Tzovaras A; Kladi-Skandali A; Michaelidou K; Zografos GC; Missitzis I; Ardavanis A; Scorilas A Clin Biochem; 2014 Dec; 47(18):257-62. PubMed ID: 25230343 [TBL] [Abstract][Full Text] [Related]
2. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer. Kontos CK; Papadopoulos IN; Scorilas A Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453 [TBL] [Abstract][Full Text] [Related]
3. Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer. Florou D; Papadopoulos IN; Scorilas A Biochem Biophys Res Commun; 2010 Jan; 391(1):214-8. PubMed ID: 19903463 [TBL] [Abstract][Full Text] [Related]
4. Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors. Talieri M; Diamandis EP; Katsaros N; Gourgiotis D; Scorilas A Thromb Haemost; 2003 Jun; 89(6):1081-8. PubMed ID: 12783122 [TBL] [Abstract][Full Text] [Related]
5. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma. Geomela PA; Kontos CK; Yiotakis I; Scorilas A J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer. Thomadaki H; Talieri M; Scorilas A Cancer Lett; 2007 Mar; 247(1):48-55. PubMed ID: 16647810 [TBL] [Abstract][Full Text] [Related]
7. Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors. Foutadakis S; Avgeris M; Tokas T; Stravodimos K; Scorilas A Urol Oncol; 2014 Jan; 32(1):39.e29-36. PubMed ID: 23790536 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia. Thomadaki H; Floros KV; Pavlovic S; Tosic N; Gourgiotis D; Colovic M; Scorilas A Clin Biochem; 2012 Nov; 45(16-17):1362-7. PubMed ID: 22728012 [TBL] [Abstract][Full Text] [Related]
9. BCL2L12: a multiply spliced gene with independent prognostic significance in breast cancer. Kladi-Skandali A; Sideris DC; Scorilas A Clin Chem Lab Med; 2018 Dec; 57(2):276-287. PubMed ID: 30325729 [TBL] [Abstract][Full Text] [Related]
10. Differential roles of Bcl2L12 and its short variant in breast cancer lymph node metastasis. Chien ST; Yang TF; Yang MC; Hsu CM; Hong YR; Lee TM Oncol Rep; 2015 Aug; 34(2):961-71. PubMed ID: 26082034 [TBL] [Abstract][Full Text] [Related]
11. BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma. Fendri A; Kontos CK; Khabir A; Mokdad-Gargouri R; Scorilas A Mol Med; 2011; 17(3-4):163-71. PubMed ID: 21152697 [TBL] [Abstract][Full Text] [Related]
12. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis. Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795 [TBL] [Abstract][Full Text] [Related]
13. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma. Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007 [TBL] [Abstract][Full Text] [Related]
14. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker. Papageorgiou SG; Kontos CK; Pappa V; Thomadaki H; Kontsioti F; Dervenoulas J; Papageorgiou E; Economopoulos T; Scorilas A Oncologist; 2011; 16(9):1280-91. PubMed ID: 21737576 [TBL] [Abstract][Full Text] [Related]
15. Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer. Mathioudaki K; Scorilas A; Papadokostopoulou A; Xynopoulos D; Arnogianaki N; Agnanti N; Talieri M Biol Chem; 2004 Sep; 385(9):779-83. PubMed ID: 15493871 [TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival. Michaelidou K; Ardavanis A; Scorilas A Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606 [TBL] [Abstract][Full Text] [Related]
17. Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells. Kontos CK; Scorilas A Gene; 2012 Aug; 505(1):153-66. PubMed ID: 22664385 [TBL] [Abstract][Full Text] [Related]
18. Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells. Floros KV; Talieri M; Scorilas A Biol Chem; 2006 Dec; 387(12):1629-33. PubMed ID: 17132110 [TBL] [Abstract][Full Text] [Related]
19. Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol. Korbakis D; Scorilas A Tumour Biol; 2012 Jun; 33(3):865-75. PubMed ID: 22238053 [TBL] [Abstract][Full Text] [Related]
20. Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study. Kontos CK; Fendri A; Khabir A; Mokdad-Gargouri R; Scorilas A BMC Cancer; 2013 Jun; 13():293. PubMed ID: 23777485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]